Posted in | News | Medical Robotics

Nevoa and LEAF Announce New Financing Partnership to Offer High-Tech Disinfection Robots for the Healthcare Industry

Nevoa Inc., a healthcare technology company based in Gilbert, Arizona, today announced a new exclusive financing partnership with LEAF Commercial Capital, Inc. ("LEAF"). This partnership offers healthcare providers additional financial flexibility in equipping their facilities with Nevoa's patented surface disinfection technology. In addition to direct purchase, customers can now obtain Nevoa's whole-room disinfecting robot with operational funds through a 0% interest rental or lease program.

"The recent attention on superior disinfection in healthcare is absolutely putting pressure on the status quo," said Ernest Cunningham, president of Nevoa Inc. "Across the country we are seeing a dramatic shift to augment disinfection protocols, improve outcomes, and better prepare for the future. Therefore, making it as simple as possible to gain access to our products is imperative. This new leasing option will help customers control cash flow and manage current financial pressures on budgets."

Nevoa's flagship product, Nimbus™, is a robot that atomizes Nevoa's hospital-grade, EPA-registered disinfectant into a dense fog in an unoccupied room. The disinfectant reaches 100% of room surfaces and also disinfects the air. Nimbus' rapid dehumidification process automatically removes any remaining disinfectant solution, allowing for immediate room reentry.

The system has been proven to be 99.9999% effective against pathogens that cause hospital-associated infections (HAIs) and is 300 times more effective than manual cleaning alone. Automating the disinfection process has also been shown to reduce labor by up to 64%, allowing EVS personnel to focus on other tasks.

"We are excited Nevoa has chosen to partner with LEAF's healthcare finance team to offer a comprehensive solution that helps Nevoa's customers more easily and affordably acquire their technology-based disinfection products," said Mark Farlin, LEAF vice president and head of healthcare and infrastructure.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.